Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy

YJ Lee, J Park, JS Uhm, JY Kim, HN Pak… - International journal of …, 2016 - Elsevier
Background The efficacy of oral anticoagulation therapy (OAT) has not been revealed in
atrial fibrillation (AF) patients with newly diagnosed cancers. This study evaluated the …
被引用次数：64 相关文章

Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy

YJ Lee, JK Park, JS Uhm, JY Kim… - INTERNATIONAL …, 2016 - scholarworks.bwise.kr
Background: The efficacy of oral anticoagulation therapy (OAT) has not been revealed in
atrial fibrillation (AF) patients with newly diagnosed cancers. This study evaluated the …

Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy

YJ Lee, J Park, JS Uhm, JY Kim… - International …, 2016 - pubmed.ncbi.nlm.nih.gov
Background The efficacy of oral anticoagulation therapy (OAT) has not been revealed in
atrial fibrillation (AF) patients with newly diagnosed cancers. This study evaluated the …

Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy

YJ Lee, J Park, JS Uhm, JY Kim, HN Pak… - International Journal of …, 2016 - infona.pl
The efficacy of oral anticoagulation therapy (OAT) has not been revealed in atrial fibrillation
(AF) patients with newly diagnosed cancers. This study evaluated the thromboembolic and …

Bleeding Risk and Major adverse Events in Patients with Cancer on Oral Anticoagulation Therapy

Y Lee, J Uhm, H Pak, B Joung - 대한내과학회추계학술발표논문집, 2015 - kiss.kstudy.com
Background: Malignancy is a well-established hypercoagulable state that predisposes to
thromboembolisms. However, the efficacy of oral anticoagulation therapy (OAT) might be …

Bleeding Risk and Major adverse Events in Patients with Cancer on Oral Anticoagulation Therapy

YJ Lee, J Park, JS Uhm, JY Kim, HN Pak, MH Lee… - kaim.or.kr
Background: Malignancy is a well-established hypercoagulable state that predisposes to
thromboembolisms. However, the efficacy of oral anticoagulation therapy (OAT) might be …

Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy

YJ Lee, JK Park, JS Uhm, JY Kim… - International …, 2016 - yonsei.elsevierpure.com
Background: The efficacy of oral anticoagulation therapy (OAT) has not been revealed in
atrial fibrillation (AF) patients with newly diagnosed cancers. This study evaluated the …

Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy

YJ Lee, J Park, JS Uhm, JY Kim… - International …, 2016 - internationaljournalofcardiology.com
Background The efficacy of oral anticoagulation therapy (OAT) has not been revealed in
atrial fibrillation (AF) patients with newly diagnosed cancers. This study evaluated the …

Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy.

YJ Lee, JK Park, JS Uhm, JY Kim, HN Pak… - … Journal of Cardiology, 2015 - europepmc.org
Background The efficacy of oral anticoagulation therapy (OAT) has not been revealed in
atrial fibrillation (AF) patients with newly diagnosed cancers. This study evaluated the …

Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy

YJ Lee, J Park, JS Uhm, JY Kim… - INTERNATIONAL …, 2016 - repository.hanyang.ac.kr
Background: The efficacy of oral anticoagulation therapy (OAT) has not been revealed in
atrial fibrillation (AF) patients with newly diagnosed cancers. This study evaluated the …